Formulating Drugs for Inhalers and Stability Issues

The main topic addressed in this paper is the formulation of pressurised metered dose inhalers and the problems associated with formulating medications for high pressure systems. Formulations for pressurised metered-dose inhalers (pMDIs) generally consist of two main types, solution and suspension-b...

Full description

Bibliographic Details
Main Authors: R. C. Toon, E. C. Preedy, P. Prokopovich
Format: Article
Language:English
Published: al-Farabi Kazakh National University 2012-11-01
Series:Eurasian Chemico-Technological Journal 
Online Access:http://ect-journal.kz/index.php/ectj/article/view/410
id doaj-840f1424b1034f2a83d74a29481a82b4
record_format Article
spelling doaj-840f1424b1034f2a83d74a29481a82b42020-11-24T21:01:22Zengal-Farabi Kazakh National UniversityEurasian Chemico-Technological Journal 1562-39202522-48672012-11-0114427128610.18321/ectj124410Formulating Drugs for Inhalers and Stability IssuesR. C. Toon0E. C. Preedy1P. Prokopovich2Nemaura Pharma Limited, Holywell Park, Loughborough, LE11 3AQ, UKSchool of Pharmacy and Pharmaceutical Sciences and School of Engineering, Cardiff University, Cardiff, CF10 3NB, UKSchool of Pharmacy and Pharmaceutical Sciences and School of Engineering, Cardiff University, Cardiff, CF10 3NB, UKThe main topic addressed in this paper is the formulation of pressurised metered dose inhalers and the problems associated with formulating medications for high pressure systems. Formulations for pressurised metered-dose inhalers (pMDIs) generally consist of two main types, solution and suspension-based systems. In the latter version, the active ingredient ideally remains mainly in the solid state, which can thus reduce problems with chemical degradation. However, the physical stability of such systems, in terms of aggregation, flocculation, creaming, sedimentation, propellant clathrates and bridging can then become problematic. The problems associated with solution-based systems revolve around the chemical stability of the active ingredients.http://ect-journal.kz/index.php/ectj/article/view/410
collection DOAJ
language English
format Article
sources DOAJ
author R. C. Toon
E. C. Preedy
P. Prokopovich
spellingShingle R. C. Toon
E. C. Preedy
P. Prokopovich
Formulating Drugs for Inhalers and Stability Issues
Eurasian Chemico-Technological Journal 
author_facet R. C. Toon
E. C. Preedy
P. Prokopovich
author_sort R. C. Toon
title Formulating Drugs for Inhalers and Stability Issues
title_short Formulating Drugs for Inhalers and Stability Issues
title_full Formulating Drugs for Inhalers and Stability Issues
title_fullStr Formulating Drugs for Inhalers and Stability Issues
title_full_unstemmed Formulating Drugs for Inhalers and Stability Issues
title_sort formulating drugs for inhalers and stability issues
publisher al-Farabi Kazakh National University
series Eurasian Chemico-Technological Journal 
issn 1562-3920
2522-4867
publishDate 2012-11-01
description The main topic addressed in this paper is the formulation of pressurised metered dose inhalers and the problems associated with formulating medications for high pressure systems. Formulations for pressurised metered-dose inhalers (pMDIs) generally consist of two main types, solution and suspension-based systems. In the latter version, the active ingredient ideally remains mainly in the solid state, which can thus reduce problems with chemical degradation. However, the physical stability of such systems, in terms of aggregation, flocculation, creaming, sedimentation, propellant clathrates and bridging can then become problematic. The problems associated with solution-based systems revolve around the chemical stability of the active ingredients.
url http://ect-journal.kz/index.php/ectj/article/view/410
work_keys_str_mv AT rctoon formulatingdrugsforinhalersandstabilityissues
AT ecpreedy formulatingdrugsforinhalersandstabilityissues
AT pprokopovich formulatingdrugsforinhalersandstabilityissues
_version_ 1716778278257164288